Corporate
  • UCB

    Created in 1928
  • Social networks

    11,166 20,115 1,808 263,438
  • Location

    All. de la Recherche 60, 1070 Anderlecht, Belgium

    Anderlecht

    Belgium

  • Engaged entities

    319
    222 95
  • Added in Motherbase

    2 Aug 2022, 2:41 p.m.
Description
  • Value proposition

    Inspired by patients. Driven by science.

    UCB – Inspired by patients. Driven by science. At UCB, we put our heart, soul and skills into making a difference for people living with severe diseases. We look to transform patients’ lives by pushing the boundaries of what is possible. With us, our talents makes the most of who they are, unlocking innovation and setting new standards for patients.

    Everything we do starts with a simple question: “How will this make a difference to the lives of people living with severe diseases?”
    And to find the answers, we connect globally with patients and their families living with the physical and social burdens of severe disease. These connections give us new perspectives, drive our innovation, and offer a hope for a new generation of therapies that will help to transform lives.

    UCB – The Facts

    With approximately 9000 employees in around 40 countries, we are a global biopharmaceutical company headquartered in Brussels, Belgium which invests more than 25% of revenue in cutting-edge scientific research to meet unmet patient needs.
    A few other reasons that make UCB an amazing place to work:
    - Promising pipeline that includes several novel molecules;
    - 2023 Key Financials: € 5.3 billion global revenue

    Specialties: Neurology, Immunology

    Neurology, Immunology, and Healthcare Innovation Beyond Medicine

Entity interactions BETA
Entity TypeTweets Articles
Duke University School of Medicine Duke University School of Medicine
Higher Education
Other

23 Oct 2018


Icahn School of Medicine at Mount Sinai Icahn School of Medicine at Mount Sinai
healthtech, Hospitals and Health Care
Other

13 Dec 2018


Interpat Interpat
legaltech, Government Administration
Other

26 Apr 2021


PhRMA PhRMA
biotech, deeptech, Pharmaceutical Manufacturing
Other

10 May 2023


MedInTechs MedInTechs
Events Services, healthtech
Other

9 Mar 2022


Johns Hopkins Technology Ventures (JHTV) Johns Hopkins Technology Ventures (JHTV)
Research Services
Other

12 Jun 2019


Truveta Truveta
healthtech, Hospitals and Health Care
Other

31 Oct 2023


Alliance maladies rares Alliance maladies rares
healthtech, Non-profit Organizations
Other

2 Jun 2024


Duke Capital Partners Duke Capital Partners
Venture Capital and Private Equity Principals
Other

2 Oct 2018


Tufts Center for the Study of Drug Development Tufts Center for the Study of Drug Development
deeptech, Pharmaceutical Manufacturing
Other

9 Aug 2022


Radars
Loading...